"Microfluidics in the Real World"

Paul Bernasconi,  Amphora Discovery Corporation

In order to build a Chemical Genomics database, Amphora Discovery is using Caliper’s microfluidics platform to screen large numbers of targets on a highly diverse chemical library. The database will provide novel validation tools and accelerate the pace of discovery of novel therapeutic agents. The generated data must be of very high quality in terms of precision, accuracy and reproducibility. Several examples will be presented that indicate that the microfluidics approach, coupled with attention to detail in compound handling, is ideally suited for this task.